Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Kalotychou

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
British Journal of Haematology|March 1, 1995
Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell/beta-thalassaemiaE Voskaridou, V Kalotychou, D Loukopoulos
Minerva Pediatrica|May 31, 2008
Unusual Gilbert's syndrome genotype in a Greek patient suffering from both Gilbert's syndrome and familial mediterranean fever. A case reportV Kalotychou, A Kanta, Y Rombos, et al.
Blood Cells, Molecules & Diseases|December 9, 2000
Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in GreeceD Loukopoulos, E Voskaridou, V Kalotychou, et al.
Panminerva Medica|July 13, 2001
Clinical significance of the molecular detection of melanoma cells circulating in the peripheral blood in melanoma patientsK Konstantopoulos, M Psatha, V Kalotychou, et al.
American Journal of Hematology|January 12, 2000
Neutrophil elastase in patients with homozygous beta-thalassemia and pseudoxanthoma elasticum-like syndromeM Samarkos, A Aessopos, C Fragodimitri, et al.
Postgraduate Medical Journal|November 8, 2005
Systolic and diastolic function in middle aged patients with sickle beta thalassaemia. An echocardiographic studyI Moyssakis, R Tzanetea, P Tsaftaridis, et al.
The West Indian Medical Journal|July 20, 2012
Mediterranean fever gene mutations in Greek patients with Behcet's diseaseK Konstantopoulos, E Kanta, V Papadopoulos, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Hydroxyurea therapy in thalassemiaD Loukopoulos, E Voskaridou, A Stamoulakatou, et al.
Haematologica|February 22, 2000
Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1)Y Rombos, R Tzanetea, K Konstantopoulos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|March 1, 1995
Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle-cell/beta-thalassaemiaE Voskaridou, V Kalotychou, D Loukopoulos
Minerva Pediatrica|May 31, 2008
Unusual Gilbert's syndrome genotype in a Greek patient suffering from both Gilbert's syndrome and familial mediterranean fever. A case reportV Kalotychou, A Kanta, Y Rombos, et al.
Blood Cells, Molecules & Diseases|December 9, 2000
Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in GreeceD Loukopoulos, E Voskaridou, V Kalotychou, et al.
Panminerva Medica|July 13, 2001
Clinical significance of the molecular detection of melanoma cells circulating in the peripheral blood in melanoma patientsK Konstantopoulos, M Psatha, V Kalotychou, et al.
American Journal of Hematology|January 12, 2000
Neutrophil elastase in patients with homozygous beta-thalassemia and pseudoxanthoma elasticum-like syndromeM Samarkos, A Aessopos, C Fragodimitri, et al.
Postgraduate Medical Journal|November 8, 2005
Systolic and diastolic function in middle aged patients with sickle beta thalassaemia. An echocardiographic studyI Moyssakis, R Tzanetea, P Tsaftaridis, et al.
The West Indian Medical Journal|July 20, 2012
Mediterranean fever gene mutations in Greek patients with Behcet's diseaseK Konstantopoulos, E Kanta, V Papadopoulos, et al.
Annals of the New York Academy of Sciences|July 21, 1998
Hydroxyurea therapy in thalassemiaD Loukopoulos, E Voskaridou, A Stamoulakatou, et al.
Haematologica|February 22, 2000
Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1)Y Rombos, R Tzanetea, K Konstantopoulos, et al.
Pageof 1